Mitochondria are targets for geranylgeranylacetone-induced cardioprotection against ischemia-reperfusion in the rat heart CARDIOMYOCYTES POSSESS ABUNDANT mitochondria, which are key organelles involved in ischemia-reperfusion injury (14, 19) . Damage to mitochondria causes reduced respiratory function and ATP synthesis, resulting in irreversible cardiomyocyte damage (14, 19) . Our laboratory has previously reported that geranylgeranylacetone (GGA), an anti-ulcer agent, induces expression of heat shock protein 72 (HSP72) and provides cardioprotection against ischemia-reperfusion injury in rat hearts (16, 25) . Nevertheless, the precise mechanisms for GGA-induced protection remain unknown. Since mitochondria have been shown to be selective targets for heat stress (HS)-induced cardioprotection (20) , we hypothesized that the preservation of mitochondrial function could be involved in GGAor HS-induced cardioprotection against ischemia-reperfusion.
The mitochondrial ATP-sensitive potassium (mitoK ATP ) channel is a putative channel in the inner mitochondrial membrane (17) . Although this channel has not yet been cloned, its pharmacological activation by nicorandil provides cardioprotection against ischemic insult or oxidative stress and its blockade by 5-hydroxydecanoate (5-HD) or glibenclamide prevents this protection (7, 24) . It has also been reported that opening of the mitoK ATP channel has an essential role in ischemic preconditioning-induced protection of mitochondria (6) .
In the present study, using rat heart and rat neonatal cultured cardiomyocytes, we investigated the mechanism by which HSP72 expression induces cardioprotection. In experiments using isolated perfused hearts, we investigated the effects of either 5-HD or glibenclamide on left ventricular (LV) functional recovery and creatine kinase (CK) release during a 30-min reperfusion following 20 min of no-flow global ischemia. At the end of the reperfusion period, the mitochondria were isolated for evaluation of respiratory function and their ultrastructure. In experiments using cultured cardiomyocytes, the effect of 5-HD on GGA-induced cardioprotective effects was investigated using small-interfering RNA (siRNA) that targets HSP72 because GGA-induced cardioprotective effects may involve HSP72 expression.
MATERIALS AND METHODS
All experimental procedures were approved by and performed in accordance with the guidelines for the care and use of laboratory animals of the Physiological Society of Oita University, Japan.
Materials. Monoclonal immunoglobulin G (IgG) cross-reactive to inducible HSP72 antibody was obtained from Stressgen Biotechnologies (Victoria, BC, Canada). Horseradish peroxidase-linked F(abЈ) 2 fragment from sheep anti-mouse immunoglobulin and reagents for Western blot assay and enhanced chemiluminescence were purchased from Amersham (Piscataway, NJ). Bradford protein assay kits were purchased from Bio-Rad (Richmond, CA). 5-HD and glibenclamide were purchased from ICN Biomedicals (Costa Mesa, CA) and Wako (Osaka, Japan), respectively. GGA was provided by Eisai (Tokyo, Japan).
Animals. Male Sprague-Dawley rats (200 -250 g) were used. GGA, as an emulsion with 5% gum arabic and 0.008% tocopherol, was given orally at a dose of 200 mg/kg (16, 25) . Rats were classified into three groups. The control group was treated with a single oral administration of vehicle. The GGA group received a single oral administration of GGA. The HS group was treated in a water bath at 43°C for 15 min (16) . Rectal temperature was monitored for confirmation of body temperature elevation. Twenty-four hours after treatment, rats were anesthetized (pentobarbital sodium, 50 mg/kg ip) and heparinized (500 IU/kg ip). Hearts were then isolated and prepared for experiments (Fig. 1A) .
Isolated perfused heart experiments. Each heart was isolated and perfused retrogradely using the Langendorff method, with KrebsHenseleit buffer (pH 7.4) containing (in mM) 118 NaCl, 4.7 KCl, 2.5 CaCl 2, 1.2 MgSO4, 1.2 KH2PO4, 25.0 NaHCO3, and 11.0 glucose, equilibrated with 95% O2-5% CO2 gas mixture at 36.5°C at a constant pressure of 75 mmHg (16, 25) . A water-filled latex balloon was inserted through the mitral orifice into the LV, and the LV enddiastolic pressure (LVEDP) was adjusted to 0 -5 mmHg. The heart was covered with water-jacketed glassware, and the relative humidity was maintained for at least 90%. The perfusion protocol is shown in Fig. 1 . Each heart from the three groups was perfused in the presence or absence of 5-HD (100 mol/l) or glibenclamide (10 mol/l). Concomitant perfusion with 5-HD or glibenclamide was initiated 10 min before the introduction of ischemia and continued to the end of the reperfusion period. The hearts were subjected to normothermic no-flow global ischemia for 20 min, followed by reperfusion for 30 min (16, 25) . The coronary effluent during the 30-min reperfusion period was collected to measure CK release. LV pressure was monitored using a pressure transducer to record the peak positive and negative first derivatives of LV pressure (dP/dt max and dP/dtmin, respectively). LV developed pressure (LVDP) was defined as the difference between the LV systolic and diastolic pressures. Coronary perfusion pressure (CPP) was defined as the hydraulic pressure measured at the level of aortic cannulation. LV pressure, CPP, and electrocardiograms were continuously recorded using a polygraph recorder (WS-681G, Nihon Kohden, Tokyo, Japan) and stored on a PCM data recorder (RD-111T, TEAC, Tokyo, Japan) for later analysis.
Western blot analysis. At the end of the reperfusion period, hearts were rapidly removed from the Langendorff apparatus and frozen in liquid nitrogen. Western blot analysis was performed as previously described (16, 25) . To analyze the expression of HSP72, frozen heart samples were homogenized with SDS sample buffer (20% glycerol, 6% SDS, and 0.12 M Tris, pH 6.8), centrifuged, and boiled. The total protein concentration of each heart was quantified by the Bradford method (4). The preparations were diluted in dissociation buffer. An equal amount of total protein from each fraction was electrophoresed by 8.5% SDS-PAGE and transferred electrophoretically to a polyvinylidene fluoride membrane. After being transferred and blocked with 0.5% nonfat milk, the membranes were incubated with antibodies. The proteins were detected by enhanced chemiluminescence with exposure to Hyperfilm. The amount of protein on the immunoblots was quantified using National Institutes of Health (Bethesda, MD) image analysis software.
Mitochondria isolation. At the end of the reperfusion period, mitochondria were isolated from the hearts by differential centrifugation (2, 22) . Briefly, hearts were dissected and immersed in ice-cold medium containing (in mM) 225 mannitol, 75 sucrose, 10 Tris, and 2 EGTA, and 0.1% bovine serum albumin (BSA) (pH 7.2 at 4°C). After the atria and major vessels were discarded, ventricles were washed in the ice-cold medium, minced, and homogenized. The homogenate was centrifuged at 800 g for 10 min at 4°C. The supernatant was retrieved and centrifuged at 7,000 g for 10 min. The resulting pellet was then resuspended in the buffer (as described above, but without EGTA) and recentrifuged at 7,000 g for 10 min. The final pellet was resuspended in the EGTA-free buffer and kept on ice.
Mitochondrial respiration. Mitochondrial oxygen consumption was measured as previously reported (2, 22) using a Clark-type oxygen electrode connected to an oxygraph (Central Kagaku, Tokyo, Japan). Mitochondria (ϳ1 mg of protein) and 0.25 mg of fat-free BSA were placed in 1 ml of respiration medium containing (in mM) 100 KCl, 75 mannitol, 25 sucrose, 0.05 EDTA (dipotassium salt), 10 Tris ⅐ HCl, and 10 KH 2PO4-Tris (pH 7.4) and stirred at 30°C. State 4 respiration was initiated using 5 mM glutamate and 5 mM malate or 5 mM succinate and 1 M rotenone. State 3 respiration was initiated by the addition of ADP to the respiration medium. The respiratory control index (RCI) was calculated as the ratio of the state 3 to state 4 mitochondrial oxygen consumption rates.
Electron microscopic findings. Isolated mitochondria were fixed in cacodylate-buffered (pH 7.4) 2.5% glutaraldehyde and paraformaldehyde at 4°C for 2 h and then fixed in cacodylate-buffered (pH 7.4) 2% osmium tetroxide and 0.5% potassium ferrocyanide at 4°C for 2 h. The preparations were dehydrated in a graded series of ethanol and embedded in epoxy resin. The preparations were then stained with uranyl acetate and lead cystate and viewed under a transmission electron microscope (JEM-100CX, JOEL, Tokyo, Japan).
GGA-induced HSP72 expression and hypoxia-reoxygenation in cardiomyocytes.
Neonatal cardiomyocytes were prepared from 3-dayold Wistar rats, as described previously (23) . Briefly, cardiomyocytes were placed on 35-mm culture dishes at a density of 5 ϫ 10 6 cells per dish and cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum at 37°C and under a mixture of 5% CO2-95% room air. On day 3, the medium was replaced with serum-free DMEM supplemented with 5 g/ml transferrin, and the cells were cultured for 24 h. GGA supplemented with tocopherol was dissolved in absolute ethanol (final concentration, Ͻ0.1%). Our preliminary experiments investigating dose-dependent changes in HSP72 expression revealed that treatment with 10 Ϫ5 M GGA induced maximal HSP72 expression (Fig. 6A) . Furthermore, experiments estimating time-dependent changes in HSP72 expression found that GGA-induced HSP72 expression reached a peak at 4 h (Fig. 6B) . According to these preliminary results, HSP72 expression was evaluated after 4 h with treatment of 10 Ϫ5 M GGA. To evaluate the effect of 5-HD on GGA treatment, the cultured myocytes were treated with 10 Ϫ5 M GGA or vehicle for 4 h in the culture medium, and 5-HD (500 M) was added 10 min before hypoxia was induced. Some cardiomyocytes were lysed for Western blot analysis. To evaluate the tolerance to hypoxia-reoxygenation, the remaining cardiomyocytes were incubated in serum-free DMEM without glucose under a hypoxic gas mixture (95% N 2-5% CO2) at 37°C for 3 h, followed by reoxygenation under a normoxic gas mixture for 1 h. The supernatant was carefully collected for lactate dehydrogenase (LDH) determination using an LDH assay kit (Eiken Chemical, Tokyo, Japan). For the apoptosis assay, cells were fixed after reoxygenation in 4% polyparaformaldehyde solution in 0.1 M NaH 2PO4 and permeabilized with 0.5% Triton X-100 (Sigma, St. Louis, MO). Apoptotic cells were detected with the in situ terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) method using an Values are means Ϯ SE; n, number of hearts. LVDP, left ventricular developed pressure; HR, heart rate; CPP, coronary perfusion pressure; dP/dtmax and dP/dtmin, peak positive and negative first derivatives of LV pressure, respectively; CNT, control; GGA, geranylgeranylacetone; HS, heat shock; 5-HD, 5-hydroxydecanoate; Glib, glibenclamide.
apoptosis kit (Medical Biological Lab, Nagoya, Japan). Slides were treated with a mixture of terminal deoxynucleotidyl tranferase, FITCdUTP, and TdT buffer II at 37°C for 1 h. After being washed with PBS, the cells were mounted with mounting medium of 4Ј,6-diamidino-2-phenylindole.
siRNA transfection. The siRNAs targeting HSP72 were obtained from Ambion (Austin, TX) and transfected into cells at a concentration of 10 nM with siPORT NeoFX Transfection (Ambion) (23) . The control cells were transfected with negative control siRNA. Twentyfour hours after transfection, cells were incubated with GGA or vehicle for 4 h. HSP72 expression was evaluated, and hypoxiareoxygenation was performed.
Statistical analysis. Data are expressed as means Ϯ SE. Serial changes in LVDP, LVEDP, CPP, heart rate, and dP/dt were analyzed by two-way ANOVA and by the Bonferroni/Dunn test, unless otherwise specified. The hemodynamic parameters at baseline, the ratio of released CK to ventricular weight, the LDH content in the cultured medium, and the percentage of apoptotic cells were compared among groups by one-way ANOVA followed by the Bonferroni/Dunn test. The relative intensity of each protein and RCI were compared using the Mann-Whitney U-test. A value of P Ͻ 0.05 was considered significant. Table 1 , LVDP, heart rate, CPP, and dP/dt did not differ among the 12 groups at baseline. Figure 2 , A and B, shows the serial changes in LVDP and dP/dt during the experimental period. The recovery of LVDP and dP/dt with reperfusion was greater in the GGA and HS groups compared with the control group (P Ͻ 0.05 for each by ANOVA). Perfusion with 5-HD abolished the improved functional recovery observed in the GGA-and HStreated hearts ( Fig. 2A) . Heart rate and CPP did not differ significantly among the 12 groups at any period (data not shown). Perfusion with glibenclamide had the same effect as 5-HD (Fig. 2B) . The amount of CK released during the 30-min reperfusion was lower in the GGA and HS groups than in the control group (P Ͻ 0.01) (Fig. 2, C and D) . Perfusion with 5-HD abolished the reduction in CK release observed in the GGA and HS groups (Fig. 2C ). Perfusion with glibenclamide had the same effect as 5-HD (Fig. 2D) .
RESULTS

Isolated perfused heart experiments. As shown in
GGA-induced cardiac HSP72 expression. Figure 3 , A and B, shows the cardiac HSP72 expression level in the hearts at the end of reperfusion. Irrespective of perfusion with 5-HD, the hearts treated with GGA or HS showed increased HSP72 expression levels compared with control hearts (P Ͻ 0.05 and P Ͻ 0.01, respectively). The HSP72 expression level in HS-treated hearts was greater than that in GGA-treated hearts (P Ͻ 0.05).
Mitochondrial respiration. Figure 4 , A and B, shows the respiratory function of mitochondria at the end of the reperfusion period. The RCIs for malate (complex I substrate)-and succinate (complex II substrate)-energized mitochondria were increased in the GGA and HS groups compared with the control group (P Ͻ 0.05 for each). Concomitant perfusion with 5-HD abolished the improved respiration function of mitochondria in GGA-and HS-treated hearts.
Electron microscopic findings. In mitochondria isolated from the control group, most of the inner and outer membranes were disrupted, displaying disrupted cristae formation and a swollen matrix (Fig. 5) . These alterations were reduced, however, in mitochondria isolated from the GGA and HS groups, although some mitochondria were substantially damaged.
GGA-induced HSP72 expression in cultured rat neonatal cardiomyocytes. Figure 6 , A and B, shows the effects of concentration-and time-dependent GGA induction of HSP72 in cultured cardiomyocytes. When assessed 4 h after GGA application, a GGA concentration of 10 Ϫ5 M induced the greatest HSP72 expression level (Fig. 6A) . HSP72 expression reached a maximum level 4 h after application of 10 Ϫ5 M GGA (Fig. 6B) .
The effect of 5-HD against GGA-induced HSP72 expression in cultured rat neonatal cardiomyocytes. Figure 6C shows representative immunoblots and relative band densities of HSP72 in cultured rat neonatal cardiomyocytes. Irrespective of the application of 5-HD, cardiomyocytes treated with GGA showed increased HSP72 expression compared with that in control cardiomyocytes (P Ͻ 0.01).
The effects of GGA and 5-HD treatment on hypoxia-reoxygenation injury in cultured rat neonatal cardiomyocytes. (Fig. 7C) . However, a concomitant application of 5-HD abolished the protective effects of GGA (0.042 Ϯ 0.006 vs. 0.016 Ϯ 0.005 IU/ml, P Ͻ 0.01).
The effect of HSP72-siRNA on HSP72 expression and hypoxia-reoxygenation injury. As shown in Fig. 8A , the HSP72-targeted siRNA effectively suppressed the GGA-induced Fig. 5 . Electron microscope results. In isolated mitochondria from the control group, most of the inner and outer membranes were disrupted, displaying destroyed cristae formation and a swollen matrix. These alterations were reduced, however, in isolated mitochondria from the GGA or HS group, although some mitochondria were still markedly damaged.
HSP72 expression in the presence or absence of 5-HD. In GGA-treated cardiomyocytes, the LDH release in response to hypoxia-reoxygenation was increased with 5-HD treatment (0.012 Ϯ 0.002 vs. 0.030 Ϯ 0.004 IU/ml, P Ͻ 0.01) (Fig. 8B) . In the absence of 5-HD, treatment with HSP72-targeted siRNA inhibited the GGA-induced protective effects on LDH release (0.012 Ϯ 0.002 vs. 0.038 Ϯ 0.008 IU/ml, P Ͻ 0.01). Concomitant treatment with 5-HD did not affect the amounts of LDH released (0.030 Ϯ 0.004 vs. 0.034 Ϯ 0.006 IU/ml, not significant).
DISCUSSION
In the present study, we demonstrated that rat hearts treated with GGA or HS were protected from ischemia-reperfusion injury. This was shown by better LV function recovery and reduced CK release during reperfusion. Preservation of mitochondrial respiratory function and structure was also demonstrated, when assessed at the end of reperfusion. These observations indicate that upregulation of HSP72 with GGA or HS protects the mitochondria from ischemia-reperfusion injury, resulting in improved preservation of cardiac function.
Regarding the role of mitochondria as a target for the protective effects of HS, Polla et al. (20) , using cultured cells, reported that treatment with HS prevented hydrogen peroxideinduced changes in mitochondrial membrane potential and cristae formation and that the protective effects of HS were well correlated with the expression of HSP72. Jayakumar et al. (15) reported that rat hearts transfected with the HSP72 gene via intracoronary infusion showed protection of mitochondrial respiratory function after ischemia-reperfusion, which was associated with improved preservation of ventricular function. They suggested that one of the mechanisms for HSP72-mediated cardioprotection may be the opening of the mitoK ATP channel, although no evidence was shown (15) . The important role of the mitoK ATP channel in myocardial ischemic tolerance after HS treatment has since been reported in animal studies, both in vitro and in vivo (1, 12, 18) . In isolated perfused rat hearts, preperfusion with either 10 M glibenclamide or 100 M 5-HD abolished the reduction in regional ischemiainduced infarct size produced by whole body HS treatment 24 h before ischemia (12) . With the use of an in vivo rabbit model of acute myocardial infarction, the reduction in infarct size with HS treatment 24 h before coronary occlusion was abolished with intravenous 0.3 mg/kg glibenclamide or 5 mg/kg 5-HD administered 10 min before coronary occlusion (18) . These studies, however, did not evaluate mitochondrial respiratory function in response to ischemia-reperfusion (1, 12, 18) . In our perfused rat heart experiment, concomitant perfusion with 100 M 5-HD or 10 M glibenclamide abolished the GGA-or HS-induced improvement in LV functional recovery during reperfusion. Furthermore, GGA-or HS-treated hearts showed preserved mitochondrial respiratory function, with preservation of mitochondrial ultrastructure, when assessed at the end of the reperfusion period. The preservation of mitochondrial respiratory function with GGA or HS was abolished by treatment with 100 M 5-HD. The pharmacological selectivity of these widely used mitoK ATP -channel blockers, at the conventional inhibitory concentrations (1, 12, 18) used in the present study, may indicate the important role of the mitoK ATP channel in GGA-or HS-induced preservation of mitochondrial respiratory function, leading to cardioprotection against ischemia-reperfusion.
The role of the mitoK ATP channel in modulating cardiac mitochondrial function has been investigated previously (6, 13) . Using isolated mitochondria from rat ventricles, Holmuhamedov et al. (13) demonstrated that the pharmacological opening of mitoK ATP channel induced rapid membrane depolarization, a decrease in the rate of ATP synthesis, and a resultant compensatory increase in the rate of mitochondrial respiration. In addition to energy production, mitochondria can store Ca 2ϩ , a function that is critical for the maintenance of cellular Ca 2ϩ homeostasis (5). The mitoK ATP channel opening was also shown to prevent cellular Ca 2ϩ overload by accumulating and retaining Ca 2ϩ in the matrix (13) . These mechanisms may underlie the cardioprotection induced by GGA or HS, as demonstrated in the present study. Further studies are needed to show how enhanced expression of HSP72, induced by GGA or HS, modulates the activity of the mitoK ATP channel. As shown in Fig. 3 , at the end of the reperfusion period, HSP72 was abundantly expressed in GGA-or HStreated heart, even in those concomitantly perfused with 5-HD. Consistent with this finding, the study of Hoag et al. (12) reported that the enhanced expression of HSP72 in HS-treated rabbit heart was not reduced by preperfusion with glibenclamide or 5-HD. Taken together, these results indicate that HSP72 degradation does not underlie the ability of 5-HD to abolish cardioprotection.
Until now, we have attributed the opening of the mitoK ATP channel, and the resultant preservation of mitochondrial func- tion, to HSP72-induced cardioprotection by GGA or HS. However, another mechanism may be involved. Following ischemia-reperfusion, cardiomyocytes die, by apoptosis as well as necrosis, and the anti-apoptotic effect of HSP72 in HS-treated cells has been reported to be related to suppression of the stress kinase c-Jun NH 2 -terminal kinase (JNK) (8) . A more recent study demonstrated that HSP72 downregulates JNK by accelerating its dephosphorylation, which reduces the susceptibility of myogenic cells to simulated ischemia-reperfusion (9) . However, HSP72 essentially acts as a molecular chaperone (3). HSP72 supports the transport of newly synthesized mitochondrial proteins, including respiratory chain enzymes, into mitochondria. The well-preserved enzyme activity of the mitochondrial respiratory chain may be due to the enhanced RCI after ischemia-reperfusion observed in mitochondria isolated from GGA-or HS-treated hearts.
Although we confirmed the protective effects of HSP72 expression in cultured cardiomyocytes using siRNA that targets HSP72, the effects of HSP72 induction could not be isolated in experiments in vivo. In addition to the HSP family, GGA is known to induce expression of many classes of protective proteins (11, 21) . Therefore, the protective effects of GGA observed in experiments in vivo could not be solely explained by the effects of HSP72. In this regard, effective elimination of HSP72 expression by HSP72-specific siRNA was observed in vitro, together with the elimination of protection against hypoxia-reoxygenation. These results strongly support the validity of our hypothesis that GGA-induced HSP72 expression provides cardioprotection.
There are several limitations in the present study. First, we evaluated the effects of HSP72-siRNA only in experiments that investigated hypoxia-reoxygenation injury, i.e., LDH release. Future studies will be required to investigate the effects of HSP72-siRNA on mitoK ATP channel effectors as RCI. Second, although 5-HD is generally regarded as a specific inhibitor of mitoK ATP channel, it has been clarified that 5-HD has multiple actions independent of mitoK ATP channel (10) . Thus alternative mechanisms should be taken into consideration as interpreting our results using 5-HD.
In conclusion, our observations indicate that the preserved mitochondrial respiratory function with GGA-induced HSP72 expression may, at least in part, have a role in cardioprotection against ischemia-reperfusion. An opening of the mitoK ATP channel may be involved in these processes.
